sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
NRIX
Updated 10/6/2026, 8:26 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics, Inc. | Sale | $134,149 | Ring Christine Chief Legal Officer | 5,786 sh | at $23.19 | Filed Oct 2, 5:21 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $149,072 | Ring Christine Chief Legal Officer | 5,787 sh | at $25.76 | Filed Sep 2, 7:42 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $36,982 | Hansen Gwenn Chief Scientific Officer | 1,452 sh | at $25.47 | Filed Sep 1, 5:19 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $108,900 | Hansen Gwenn Chief Scientific Officer | 4,356 sh | at $25.00 | Filed Aug 5, 6:59 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $100,142 | Hansen Gwenn Chief Scientific Officer | 4,111 sh | at $24.36 | Filed Aug 5, 6:39 AM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $115,989 | van Houte Hans Chief Financial Officer | 4,761 sh | at $24.36 | Filed Aug 4, 9:41 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $382,358 | Ring Christine Chief Legal Officer | 16,589 sh | at $23.05 | Filed Aug 3, 5:51 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $66,524 | van Houte Hans Chief Financial Officer | 2,845 sh | at $23.38 | Filed Jul 30, 5:58 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $89,954 | Ring Christine Chief Legal Officer | 3,847 sh | at $23.38 | Filed Jul 30, 5:56 PM ET | Filing | |
| NRIX Nurix Therapeutics, Inc. | Sale | $89,954 | Hansen Gwenn Chief Scientific Officer | 3,847 sh | at $23.38 | Filed Jul 30, 5:50 PM ET | Filing |